Portrait of Kean, Thomas H.

Kean, Thomas H.

U.S. Representative NJ-7 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
174
Buys / sells
48% / 42%
Last trade
Jul 22, 2026
Last filing
Aug 18, 2026

Latest disclosed trades

Latest 10 of 174
Ticker Type Traded
SYK Sell Jul 22, 2026
GOOGL Sell Jul 22, 2026
TOST Buy Jul 8, 2026
AMZN Buy Jul 8, 2026
EQT Buy Jul 7, 2026
ESAB Buy Jul 7, 2026
ADI Sell Jun 30, 2026
SPGI Sell Jun 29, 2026
JNJ Sell Jun 29, 2026
MKL Sell Jun 29, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Kean, Thomas H. stock trade activity

FilingIQ has indexed 174 congressional stock trade disclosures for Kean, Thomas H.. The most recent disclosed transaction is dated Jul 22, 2026.

Across the full history, 84 purchases and 73 sales have been disclosed under the STOCK Act.

Top tickers traded by Kean, Thomas H.

Frequently asked

How many stock trades has Kean, Thomas H. disclosed?
FilingIQ tracks 174 Periodic Transaction Report disclosures for Kean, Thomas H., with the most recent dated Jul 22, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Kean, Thomas H. a net buyer or net seller?
Across the disclosed trade history, 84 (48%) were purchases and 73 (42%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Kean, Thomas H. come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.